Chitosan/beta-lactoglobulin core-shell nanoparticles as nutraceutical carriers.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 15885766.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chitosan (CS)/beta-lactoglobulin (betalg) core-shell nanoparticles (CS-betalg nanoparticle) were successfully prepared with the aim of developing a biocompatible carrier for the oral administration of nutraceuticals. The effects of pH and initial concentrations (C(beta)(lg)) of native and denatured betalg on the properties of the nanoparticles were investigated. Uniform nanoparticles were prepared by ionic gelation with sodium tripolyphosphate (TPP). The surface charge of the particles was positive, with a zeta potential of 20-60 mV. (beta)lg loading efficiency (LE) spanned a broad range (1-60%); and was highly sensitive to formulation pH. This adsorption can be mainly attributed to electrostatic, hydrophobic interactions and hydrogen bonding between (beta)lg and CS. Brilliant blue (BB) release experiments showed that the nanoparticles prepared with native (beta)lg had favorable properties to resist acid and pepsin degradation in simulated gastric conditions unlike those prepared with denatured (beta)lg or denatured (beta)lg crosslinked with Ca2+. When transferred to simulated intestinal conditions, the (beta)lg shells of the nanoparticles were degraded by pancreatin.
Medical subject headings
- Chitosan
- Drug Carriers
- Lactoglobulins
- Nanostructures